Cancer Research AACR Membership  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heller, J. D.
Right arrow Articles by Huang, R. C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heller, J. D.
Right arrow Articles by Huang, R. C. C.
[Cancer Research 61, 5499-5504, July 15, 2001]
© 2001 American Association for Cancer Research


Experimental Therapeutics

Tetra-O-methyl Nordihydroguaiaretic Acid Induces G2 Arrest in Mammalian Cells and Exhibits Tumoricidal Activity in Vivo1

Jonathan D. Heller, Jennifer Kuo, T. C. Wu, W. Martin Kast and Ru Chih C. Huang2

Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218 [J. D. H., J. K., R. C. C. H.]; Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205 [T. C. W.]; and Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University, Chicago, Illinois 60626 [W. M. K.]

The transcription inhibitor tetra-O-methyl nordihydroguaiaretic acid (M4N) was found to arrest the proliferation of C3, C33a, CEM-T4, and TC-1 cells in culture at the G2 stage of the cell cycle. Investigation into the mechanism of arrest revealed that M4N reduces mRNA levels and subsequent protein production of the cyclin-dependent kinase CDC2, resulting in the inactivation of the CDC2/cyclin B complex (maturation promoting factor). When injected intratumorally in a C3-cell induced C57bl/6 mouse tumor model system, M4N demonstrated substantial tumoricidal activity that correlated with a reduction in tumor cell CDC2 protein levels. These findings suggest that M4N may be a useful chemotherapeutic agent for the control of unregulated cellular proliferation.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
H.-C. Yeh, C. M. Puleo, T. C. Lim, Y.-P. Ho, P. E. Giza, R. C. C. Huang, and T.-H. Wang
A microfluidic-FCS platform for investigation on the dissociation of Sp1-DNA complex by doxorubicin
Nucleic Acids Res., December 4, 2006; 34(21): e144 - e144.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Park, C.-C. Chang, Y.-C. Liang, Y. Chung, R. A. Henry, E. Lin, D. E. Mold, and R. C. C. Huang
Systemic Treatment with Tetra-O-Methyl Nordihydroguaiaretic Acid Suppresses the Growth of Human Xenograft Tumors
Clin. Cancer Res., June 15, 2005; 11(12): 4601 - 4609.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-C. Chang, J. D. Heller, J. Kuo, and R. C. C. Huang
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression
PNAS, September 7, 2004; 101(36): 13239 - 13244.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.